SENESTECH INC (SNES)
US81720R5054 - Common Stock
SNES gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 198 industry peers in the Pharmaceuticals industry. The financial health of SNES is average, but there are quite some concerns on its profitability. SNES shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
SNES had negative earnings in the past year.
In the past year SNES has reported a negative cash flow from operations.
SNES had negative earnings in each of the past 5 years.
In the past 5 years SNES always reported negative operating cash flow.
1.2 Ratios
SNES has a Return On Assets of -105.72%. This is amonst the worse of the industry: SNES underperforms 83.08% of its industry peers.
SNES's Return On Equity of -121.40% is on the low side compared to the rest of the industry. SNES is outperformed by 64.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -105.72% | ||
| ROE | -121.4% | ||
| ROIC | N/A |
ROA(3y)-106.9%
ROA(5y)-132.23%
ROE(3y)-129.16%
ROE(5y)-198.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 44.77%, SNES is in line with its industry, outperforming 58.97% of the companies in the same industry.
In the last couple of years the Gross Margin of SNES has grown nicely.
SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y17.7%
2. Health
2.1 Basic Checks
SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SNES has more shares outstanding
SNES has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNES has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -24.48, we must say that SNES is in the distress zone and has some risk of bankruptcy.
SNES's Altman-Z score of -24.48 is on the low side compared to the rest of the industry. SNES is outperformed by 89.23% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that SNES is not too dependend on debt financing.
SNES's Debt to Equity ratio of 0.02 is in line compared to the rest of the industry. SNES outperforms 52.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -24.48 |
ROIC/WACCN/A
WACC9.1%
2.3 Liquidity
SNES has a Current Ratio of 8.49. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SNES (8.49) is better than 81.54% of its industry peers.
SNES has a Quick Ratio of 7.48. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
SNES's Quick ratio of 7.48 is fine compared to the rest of the industry. SNES outperforms 79.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.49 | ||
| Quick Ratio | 7.48 |
3. Growth
3.1 Past
SNES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.69%, which is quite impressive.
SNES shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.02%.
Measured over the past years, SNES shows a very strong growth in Revenue. The Revenue has been growing by 31.80% on average per year.
EPS 1Y (TTM)83.69%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q97.48%
Revenue 1Y (TTM)16.02%
Revenue growth 3Y66.17%
Revenue growth 5Y31.8%
Revenue growth Q2Q-1.67%
3.2 Future
The Earnings Per Share is expected to grow by 25.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, SNES will show a very strong growth in Revenue. The Revenue will grow by 85.15% on average per year.
EPS Next Y97.81%
EPS Next 2Y40.9%
EPS Next 3Y25.72%
EPS Next 5YN/A
Revenue Next Year76.3%
Revenue Next 2Y87.78%
Revenue Next 3Y85.15%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
SNES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNES. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SNES's earnings are expected to grow with 25.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.9%
EPS Next 3Y25.72%
5. Dividend
5.1 Amount
SNES does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SENESTECH INC
NASDAQ:SNES (5/3/2024, 7:19:01 PM)
0.8622
0 (-0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.43M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -105.72% | ||
| ROE | -121.4% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.77% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 8.49 | ||
| Quick Ratio | 7.48 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.69%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y97.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.02%
Revenue growth 3Y66.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y